SectorBiotechnology Ⅲ
Established Date22/08/2012
Listing Date16/10/2014
ExchangeNASDAQ Stock Exchange
Full-time Employees14
Fiscal Year Ends31/12
Security TypeCommon stock
Office address1280 Rancho Conejo Blvd, Thousand Oaks, CA 91320
BusinessDevelops T-cell immunotherapies for cancer and autoimmune disease.
IntroductionAtara Biotherapeutics, Inc., was incorporated in Delaware on August 22, 2012. The company is a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop translational therapies for patients with cancer and autoimmune diseases.